Purinergic and Pyrimidinergic Signalling II Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function

Physiological, pharmacological and molecular biological data generated over the past three decades have demonstrated the existence of two major families of extracellular receptors, the P1, a family of four G-protein coupled receptors and the P2, a family of at least 12 receptors responsive to purine...

Full description

Bibliographic Details
Other Authors: Abracchio, Maria P. (Editor), Williams, Michael (Editor)
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2001, 2001
Edition:1st ed. 2001
Series:Handbook of Experimental Pharmacology
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03056nmm a2200385 u 4500
001 EB000665270
003 EBX01000000000000000518352
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9783642569210 
100 1 |a Abracchio, Maria P.  |e [editor] 
245 0 0 |a Purinergic and Pyrimidinergic Signalling II  |h Elektronische Ressource  |b Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function  |c edited by Maria P. Abracchio, Michael Williams 
250 |a 1st ed. 2001 
260 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2001, 2001 
300 |a XXVIII, 442 p  |b online resource 
505 0 |a Section III: Cardiovascular and Renal Systems -- 16 P1 Receptors in the Cardiovascular System -- 17 P1 and P2 Receptors in the Renal System -- 18 P2 Receptors in the Cardiovascular System -- 19 Roles of Purines and Pyrimidines in Endothelium -- 20 P1 and P2 Receptors in Platelets -- 21 Purinergic Signalling in Gut -- 22 P1 Receptors in the Respiratory System -- 23 P2 Receptors in the Respiratory System -- Section IV: Immune System -- 24 Role of P1 Receptors in Inflammation -- 25 Role of P2 Receptors in the Immune System -- 26 On the Role of the P2X7 Receptor in the Immune System -- Section V: Endocrine System -- 27 Purinergic Receptors and the Pharmacology of Type 2 Diabetes -- 28 Purinergic and Pyrimidinergic Receptor Signaling in Bone Cells -- 29 Clinical Opportunities in Purinergic Neuromodulation 
653 |a Cell Biology 
653 |a Medicine / Research 
653 |a Cytology 
653 |a Biology / Research 
653 |a Immunology 
653 |a Human Physiology 
653 |a Human physiology 
653 |a Endocrinology 
653 |a Biomedical Research 
653 |a Pharmacology 
700 1 |a Williams, Michael  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
490 0 |a Handbook of Experimental Pharmacology 
028 5 0 |a 10.1007/978-3-642-56921-0 
856 4 0 |u https://doi.org/10.1007/978-3-642-56921-0?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 615 
520 |a Physiological, pharmacological and molecular biological data generated over the past three decades have demonstrated the existence of two major families of extracellular receptors, the P1, a family of four G-protein coupled receptors and the P2, a family of at least 12 receptors responsive to purine (ATP, ADP) and pyrimidine (UTP) nucleotides through which adenosine and ATP can function as extracellular messengers. The present two-part volume represents an integrated compendium of invited chapters by leading researchers in the area focusing on advances in the understanding of purinergic and pyrimidinergic signaling systems, their role(s) in tissue function and pathophysiology and advances in developing potential new medications based on the modulation of P1 and P2 receptor signaling processes. The volumes will thus provide the reader with a topical, comprehensive and integrated overview of this important area